Vimarsana
Biggest News Aggregation in the World

Page 40 - Looking Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Looking Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Looking Statement Today - Breaking & Trending Today

Merck's KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Muscle-Invasive Urothelial Carcinoma (MIUC) After Surgery | Region - Vimarsana News

Merck's KEYTRUDA® (pembrolizumab) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Muscle-Invasive Urothelial Carcinoma (MIUC) After Surgery | Region

RAHWAY, N.J.--(BUSINESS WIRE)--Oct 5, 2023--

Insulet Announces CFO Transition - Vimarsana News

Insulet Announces CFO Transition

Reaffirms Guidance for Third Quarter and Fiscal Year 2023ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Wayde McMillan has decided to step down from his role as...

Ceridian Introduces Dayforce Alumni Network - Vimarsana News

Ceridian Introduces Dayforce Alumni Network

Organizations can now bolster their talent pool instantly by leveraging their alumni workforce

Merck Animal Health Expands Voluntary Recall with 4 Additional Lots of Banamine/Banamine-S - Vimarsana News

Merck Animal Health Expands Voluntary Recall with 4 Additional Lots of Banamine/Banamine-S

Merck has added new lots of Banamine to their previous recall.

FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients - Vimarsana News

FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients

/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, today announced the Pre-IND meeting requested on September...